# Nicolaus Henke

> Nicolaus Henke is a seed investor backing Information Technology and SaaS. See 3 investments, round sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Location: London, United Kingdom
- Total investments: 3
- Last investment: Apr 2023
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/nicolaus-henke-100bab114/

Nicolaus Henke is a senior partner at McKinsey & Company, where he advises leading companies on how to improve decision making and performance through advanced analytics, artificial intelligence, and end-to-end data enabled transformations, and is the global leader of McKinsey Analytics, which has more than 2,000 dedicated analyticspractitioners and translators, where he oversees partnerships between McKinsey and the wider artificial intelligence, data, and computing ecosystem. Nicolaus is the chairman of QuantumBlack (acquired by McKinsey in 2015), a company operating at the intersection of strategy, technology, and design, and a member of McKinsey’s global board, the Shareholder’s Council. He helped found and is a member of the Board of Innovative Healthcare Delivery at Duke Medicine and serves on the Dean’s Advisory Council at Harvard’s Kennedy School. Nicolaus frequently speaks on big data, analytics, and healthcare topics at global forums such as the World Economic Forum, the Milken Institute, and Forbes. He holds a master’s degree and PhD in business from the University of Münster, Germany, and a master’s in public administration from Harvard University, where he was a John J. McCloy Scholar.

## Contacts

5 contacts available for Nicolaus Henke: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/nicolaus-henke?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Information Technology | 2 | 67% |
| SaaS | 1 | 33% |
| Medical | 1 | 33% |
| Training | 1 | 33% |
| E-Learning | 1 | 33% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 67% |
| Pre-Seed | 1 | 33% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Little Journey | Little Journey offers assistance to kids and their families who are getting medical treatments or taking part in scientific trials. The company was founded in 2018. | $3.1M | Seed | Apr 14, 2023 | https://littlejourney.health |
| Oxford Medical Simulation | Oxford Medical Simulation delivers virtual reality medical simulation, training healthcare professionals to provide consistently world-class patient management without risking lives. Medical simulation has become central to medical training and is highly effective. However, it is expensive, low throughput, and not widely accessible. Healthcareworkers therefore struggle to get the training they need to deliver optimal patient care. | $2.4M | Seed | Oct 27, 2022 | https://oxfordmedicalsimulation.com/ |
| seedata.io | Seedata.io is a cybersecurity deception-technology platform to help businesses identify previously undetected data leakage incidents, significantly reducing incident costs. It identifies previously undetected data leakage incidents. The company using a combination of deception technology and threat intelligence to help businesses detect databreaches faster. They enable detection without compromising real data by using decoys or traps to trick cybercriminals into stealing or interacting with fake data.Seedata.io was founded by Enrico Faccioli and Matt Holland in 2021. | $890.7K | Pre-Seed | Aug 03, 2021 | https://www.seedata.io |

3 of 3 investments shown.

## Co-investors
- [ACF Investors](https://shizune.co/investors/profile/angel-cofund) — VC Fund, 1 deal together
- [Calm/Storm VC](https://shizune.co/investors/profile/calm-storm-ventures) — VC Fund, 1 deal together
- [CyLon Ventures](https://shizune.co/investors/profile/cylon) — VC Fund, 1 deal together
- [Octopus Ventures](https://shizune.co/investors/profile/octopus-ventures) — VC Fund, 1 deal together
- [Osney Capital](https://shizune.co/investors/profile/osney-capital) — VC Fund, 1 deal together
- [Triple Point Ventures](https://shizune.co/investors/profile/triple-point) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [Fuel Ventures](https://shizune.co/investors/profile/fuel-ventures-fund) — VC Fund
- [Business Growth Fund](https://shizune.co/investors/profile/business-growth-fund) — VC Fund

## Featured in investor lists
- [Medical Angel Investors in United Kingdom](https://shizune.co/investors/medical-angel-investors-united-kingdom)

## FAQ

### What does Nicolaus Henke invest in?

Nicolaus Henke invests primarily in Information Technology, SaaS and Medical startups, most often at Seed and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Nicolaus Henke?

Public channels for Nicolaus Henke include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Nicolaus Henke last invest?

The most recent investment recorded for Nicolaus Henke closed in Apr 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co